Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Current Oncology Reports
|
June 14, 2021
ROS1 Targeted Therapies: Current Status
Christine M Azelby, Mandy R Sakamoto, Daniel W Bowles
Clinical Lung Cancer
|
December 23, 2018
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib
Mandy R Sakamoto, Justin M Honce, Deborah L Lindquist, et al.
Journal of Telemedicine and Telecare
|
October 23, 2012
A teledermatology care management protocol for tracking completion of teledermatology recommendations
Kristin L Eastman, Marie C Lutton, Gregory J Raugi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer
Mandy R Sakamoto, Megan Eguchi, Christine M Azelby, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Current Oncology Reports
|
June 14, 2021
ROS1 Targeted Therapies: Current Status
Christine M Azelby, Mandy R Sakamoto, Daniel W Bowles
Clinical Lung Cancer
|
December 23, 2018
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib
Mandy R Sakamoto, Justin M Honce, Deborah L Lindquist, et al.
Journal of Telemedicine and Telecare
|
October 23, 2012
A teledermatology care management protocol for tracking completion of teledermatology recommendations
Kristin L Eastman, Marie C Lutton, Gregory J Raugi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer
Mandy R Sakamoto, Megan Eguchi, Christine M Azelby, et al.
Page
of 1